Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, metaanalýza, systematický přehled
PubMed
31172281
DOI
10.1007/s00345-019-02825-4
PII: 10.1007/s00345-019-02825-4
Knihovny.cz E-zdroje
- Klíčová slova
- Alcohol consumption, Bladder cancer, Cancer risk,
- MeSH
- hodnocení rizik MeSH
- lidé MeSH
- nádory močového měchýře epidemiologie etiologie MeSH
- pití alkoholu škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- systematický přehled MeSH
BACKGROUND: Epidemiologic studies that investigated alcohol consumption in relation to the risk of bladder cancer (BCa) have demonstrated inconsistent results. We conducted a systematic review and meta-analysis of the literature to investigate the association of alcohol including different types of alcoholic beverages consumption with the risk of BCa. MATERIALS AND METHODS: A systematic search of Web of Science, Medline/PubMed and Cochrane library was performed in May 2018. Studies were considered eligible if they assessed the risk of BCa due to alcohol consumption (moderate or heavy dose) and different types of alcoholic beverages (moderate or heavy dose) in multivariable analysis in the general population (all genders, males or females) or compared with a control group of individuals without BCa. STUDY DESIGN: observational cohorts or case-control. RESULTS: Sixteen studies were included in this meta-analysis. Moderate and heavy alcohol consumption did not increase the risk of BCa in the entire population. Sub-group and sensitivity analyses revealed that heavy alcohol consumption increased significantly the risk of BCa in the Japanese population, RR 1.31 (95% CI 1.08-1.58, P < 0.01) in the multivariable analysis, and in males RR of 1.50 (95% CI 1.18-1.92, P < 0.01), with no significant statistical heterogeneity. Moreover, heavy consumption of spirits drinks increased the risk of BCa in males, RR 1.42 (95% CI 1.15-1.75, P < 0.01). CONCLUSION: In this meta-analysis, moderate and heavy alcohol consumption did not increase the risk of bladder cancer significantly. However, heavy consumption of alcohol might increase the risk of BCa in males and in some specific populations.
Department of Urology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Urology Jikei University School of Medicine Tokyo Japan
Department of Urology Rennes University Hospital Rennes France
Department of Urology University of Bern Bern Switzerland
Department of Urology University of Texas Southwestern Medical Center Dallas TX USA
Department of Urology Weill Cornell Medical College New York NY USA
Division of Urology European Institute of Oncology Milan Italy
Zobrazit více v PubMed
Int J Epidemiol. 1982 Sep;11(3):212-7 PubMed
J Clin Epidemiol. 2002 Jul;55(7):637-41 PubMed
Eur Urol. 2017 Mar;71(3):447-461 PubMed
Scand J Urol Nephrol. 1983;17(3):307-12 PubMed
Gastroenterology. 2015 Dec;149(7):1700-15 PubMed
Lancet Oncol. 2009 Nov;10(11):1033-4 PubMed
Prostate. 1993;22(3):253-64 PubMed
Cancer. 1988 Jan 15;61(2):402-8 PubMed
Int J Urol. 2004 Jan;11(1):11-9 PubMed
CA Cancer J Clin. 2018 Nov;68(6):394-424 PubMed
BJU Int. 2013 Apr;111(4):589-95 PubMed
Hinyokika Kiyo. 1995 Dec;41(12):969-77 PubMed
J Natl Cancer Inst. 2004 Sep 15;96(18):1397-400 PubMed
Eur J Epidemiol. 1987 Dec;3(4):365-9 PubMed
Int J Cancer. 2007 Aug 15;121(4):839-45 PubMed
J Natl Cancer Inst. 2009 Mar 4;101(5):296-305 PubMed
BMJ. 2014 Jan 24;348:f7450 PubMed
Curr Opin Urol. 2018 Jan;28(1):88-92 PubMed
Am J Public Health. 1987 Oct;77(10):1298-300 PubMed
Eur Urol Focus. 2015 Aug;1(1):17-27 PubMed
Am J Epidemiol. 1983 Nov;118(5):720-7 PubMed
Int J Cancer. 2001 Sep;93(6):880-7 PubMed
Am J Epidemiol. 2001 Jan 1;153(1):38-41 PubMed
Tohoku J Exp Med. 2016;239(1):9-15 PubMed
Urology. 1999 Nov;54(5):823-8 PubMed
Int J Cancer. 2017 Dec 15;141(12):2480-2488 PubMed
Am J Epidemiol. 1989 Dec;130(6):1159-63 PubMed
Cancer. 1992 Apr 1;69(7):1776-90 PubMed
Ann Oncol. 2012 Jun;23(6):1586-93 PubMed
Eur Urol. 2013 Apr;63(4):724-32 PubMed
Eur J Epidemiol. 1997 Oct;13(7):795-800 PubMed
Minerva Urol Nefrol. 2016 Aug;68(4):381-95 PubMed
Am J Epidemiol. 1988 Jun;127(6):1179-91 PubMed
BMJ. 1997 Sep 13;315(7109):629-34 PubMed
Carcinogenesis. 1981;2(4):343-7 PubMed
Int J Cancer. 2017 Nov 15;141(10):1963-1970 PubMed
Eur Urol. 2016 Feb;69(2):300-10 PubMed
Eur J Nutr. 2020 Feb;59(1):287-296 PubMed
Nutr Cancer. 1997;29(2):163-8 PubMed
Cancer Detect Prev. 2009;32(5-6):352-62 PubMed
JAMA. 2000 Apr 19;283(15):2008-12 PubMed
Nature. 2016 Sep 14;537(7620):S103-4 PubMed
Int Urol Nephrol. 2008;40(3):643-7 PubMed
Nat Rev Urol. 2015 Oct;12(10):585-92 PubMed
Cancer Epidemiol. 2017 Jun;48:36-40 PubMed
Cancer. 2005 Dec 1;104(11):2400-8 PubMed
Carcinogenesis. 2016 Jun;37(6):583-588 PubMed
Curr Opin Urol. 2018 Jan;28(1):80-87 PubMed
J Natl Cancer Inst. 1980 Apr;64(4):701-13 PubMed
Cancer Causes Control. 1994 Jul;5(4):326-32 PubMed
Am J Epidemiol. 1991 Feb 1;133(3):230-9 PubMed
Eur Urol. 2015 Nov;68(5):868-79 PubMed
Eur J Epidemiol. 1999 May;15(5):411-9 PubMed